Mode
Text Size
Log in / Sign up

Eating disorders

6 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials for eating disorders

27 trials tracked for eating disorders: 5 in phase 3 or 4 and 1 with published results. The most-cited published study has 391 citations.

27Trials tracked
5Phase 3 & 4
0Recruiting
1With published results
Phase distribution
Phase 4 3 Phase 3 2 Phase 2 4 Phase 1 2 Other / NA 16
  1. Phase 4 Fluoxetine to Prevent Relapse and Enhance Psychological Recovery in Women With Anorexia Nervosa Completed · 391 cited
  2. Phase 4 Monoamine Contributions to Neurocircuitry in Eating Disorders Completed
  3. Phase 4 Effectiveness of Atypical Antipsychotic Medication for Outpatients With Anorexia Nervosa Completed
  4. Phase 3 Effects of Denosumab on Bone Mineral Density in Women With Anorexia Nervosa: A Pilot Study Completed
  5. Phase 3 Effects of Romosozumab on Bone Density in Women With Anorexia Nervosa Completed
  6. Phase 2 Effectiveness of Olanzapine Versus Placebo in Treating Outpatients With Anorexia Nervosa Completed
Show 21 more trials
  1. Phase 2 Hormonal Factors in the Treatment of Anorexia Nervosa Completed
  2. Phase 2 Effect of Growth Hormone on Bone Metabolism in Anorexia Nervosa Completed
  3. Phase 2 Effectiveness of Antibiotic Treatment for Reducing Binge Eating and Improving Digestive Function in Bulimia Nervosa Completed
  4. Phase 1 Leveraging Social Media to Identify and Connect Teens With Eating Disorders to a Mobile Guided Self-Help Mobile Intervention Completed
  5. Phase 1 Naltrexone Neuroimaging Completed
  6. N/A Treatment Uptake Chatbot for Eating Disorders Completed
  7. N/A An fMRI Study of Self-regulation in Adolescents With Bulimia Nervosa Completed
  8. N/A Comparing the Effectiveness of Two Therapies to Treat Signs of Anorexia Nervosa in Adolescents Completed
  9. N/A Harnessing Mobile Technology to Reduce Mental Health Disorders in College Populations Completed
  10. N/A Efficacy Trial of a Dissonance Based Eating Disorder Program Completed
  11. N/A Eating Disorder Prevention Program for Women With T1D Completed
  12. N/A Adding Guided Self-Help Group Therapy to the Alli Weight Loss Program in Treating Binge Eating Disorder Completed
  13. N/A The Body Project: Comparing the Effectiveness of an In-person and Virtually Delivered Intervention. Completed
  14. N/A Multi-Family Group Therapy for Adult Eating Disorders Completed
  15. N/A Evaluation of the Communities of Healing Mentorship/Support Group Program: Assessment of Preliminary Efficacy Completed
  16. N/A Improving Weight Loss Outcomes for Binge Eating Disorder. Completed
  17. N/A Neuromodulation Enhanced Cognitive Restructuring: A Proof of Concept Study Completed
  18. N/A MUMMIBODIES. Eating Disorders, Pregnancy and Post Partum Period. Completed
  19. N/A Efficacy of the Female Athlete Body Project (FAB) Completed
  20. N/A Motivate: A Web-based Intervention Completed
  21. N/A Risk of Mental Health Conditions in Children and Young Adults With Inflammatory Bowel Disease and Influence on Health Completed

Showing the 27 most-cited and recently-updated of 27 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.

Questions about eating disorders

Do GLP-1 agents address eating disorders through appetite and gut-brain signaling pathways?

GLP-1 agents address eating disorders by targeting appetite and gut-brain signaling pathways that regulate food reward and intake.

Full answer →